Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DSM Biologics, a provider of custom contract manufacturing services, and Crucell, a biopharmaceutical company, have entered into an agreement with Bioceros, a biopharmaceutical R&D contract organization of Utrecht, The Netherlands to join their vendor network.
Subscribe to our email newsletter
Under the terms of the agreement, Bioceros will be a pre-approved cell line generation partner for licensees of the PER.C6 cell line located in the EU. Other terms of the agreement were not disclosed.
The PER.C6 technology platform has been developed for the large-scale manufacture of biopharmaceutical products such as recombinant proteins, including monoclonal antibodies.
Karen King, president of DSM Biologics, said: “The growing number of PER.C6 licensees requires that we expand the possibilities for our licensees to obtain services like cell line generation. We are confident that Bioceros’s excellent experience and service level will provide our European licensees additional options to move their PER.C6 programs forward successfully.”